Adjuvant chemotherapy improves survival in early ovarian cancerBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7382.181 (Published 25 January 2003) Cite this as: BMJ 2003;326:181
- Susan Mayor
Immediate treatment with chemotherapy after surgery significantly improves survival and reduces recurrence of cancer in women with early ovarian cancer, show two major international trials published this week.
The first trial, the international collaborative ovarian neoplasm trial 1, randomly assigned 477 women with early stage epithelial ovarian cancer to receive platinum based adjuvant chemotherapy immediately after surgery or to receive no adjuvant chemotherapy until clinically indicated when further symptoms developed (Journal of the National Cancer Institute 2003; 95:125-32). It is the largest clinical trial to be carried out in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial